Companies: 10,795·Total market cap: $144.5T
Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUPNASDAQHealthcare● Active
$4.67
+$0.18(+4.01%)
Market Cap$25239253
P/E Ratio—
52W High$21.4
52W Low$3.645
Overview

Neuphoria Therapeutics Inc. (NEUP) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NEUP · as of Sep 29, 2025

Latest filing snapshot

7
-1-12.50%vs prior year

Neuphoria Therapeutics Inc. (NEUP) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-06-30·Full-time · Global
Total Employees
7
Change (1Y)
-1
Growth % (1Y)
-12.50%
Revenue / Employee
$2.24M
Net Income / Employee
$-52.8K
Market Cap
$25M

NEUP Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-09-297-1-12.50%
2024-09-308+1+14.29%
2023-10-187+1+16.67%
2022-10-146——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Medical - Pharmaceuticals
#SymbolCompanyEmployees
#1
Check-Cap Ltd.
CHEK
Check-Cap Ltd.
85#2
Biomerica, Inc.
BMRA
Biomerica, Inc.
64#3
Inspira Technologies Oxy B.H.N. Ltd.
IINN
Inspira Technologies Oxy B.H.N. Ltd.
37#4
BioCardia, Inc.
BCDA
BioCardia, Inc.
17#5
Aprea Therapeutics, Inc.
APRE
Aprea Therapeutics, Inc.
8#6
Neuphoria Therapeutics Inc.
NEUP
Neuphoria Therapeutics Inc.YOU
7#7
Alzamend Neuro, Inc.
ALZN
Alzamend Neuro, Inc.
4
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NEUP peer comparison

About NEUP employees

NEUP Employees · Headcount

Neuphoria Therapeutics Inc. (NEUP) employee data is sourced from the annual SEC 10-K filing. As of 2025, Neuphoria Therapeutics Inc. had 7 full-time employees globally. Full-time employees only. Global consolidated headcount.

Neuphoria Therapeutics Inc. employs 7 full-time employees as of the latest filing within the Medical - Pharmaceuticals industry. Revenue per employee stands at $2.24M, reflecting the company's operational efficiency.

Neuphoria Therapeutics Inc.'s workforce decreased by 1 (12.50%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Neuphoria Therapeutics Inc.'s revenue per employee of $2.24M positions it among the notable performers in the Medical - Pharmaceuticals sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

NEUP Employees · 5 questions

As of the latest SEC 10-K filing (2025), Neuphoria Therapeutics Inc. had 7 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Neuphoria Therapeutics Inc. employee counthow many employees does Neuphoria Therapeutics Inc. haveNEUP total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-09-29